Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gecacitinib (Jaktinib) + Glucocorticoids for First-line Grade II-IV aGVHD
NCT07285889Phase 2Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in Acute Graft-Versus-Host Disease (aGvHD), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Started Dec 2025; status: recruiting.
02
Drugs
jaktinib
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT07285889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07285889.